查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1498686

全球药物器材组合产品市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Drug Device Combination Products Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 175 Pages | 商品交期: 最快1-2个工作天内

价格

全球药物器材组合产品市场需求预计将从2023年的1,446.6亿美元达到2032年近2,967.4亿美元的市场规模，2024-2032年研究期间的复合年增长率为8.31%。

药物器材组合产品是将药物或生物物质与医疗器材结合以提供治疗效果或执行特定治疗功能的医疗产品。这些产品旨在提供标靶药物输送、增强药物疗效、提高患者依从性，或实现仅使用传统药物配方或医疗设备无法实现的新颖治疗方式。这些产品涵盖各种医疗保健干预措施，包括药物洗脱支架、胰岛素帮浦、避孕植入物和吸入装置。这些创新产品在精准医疗、个人化治疗和病患便利性方面具有潜在优势，推动医疗进步并改善各个治疗领域的病患治疗效果。

市场动态

对定製药物和标靶治疗的需求不断增长，推动了创新药物器材组合产品的开发，这些产品提供精确的药物传输机制并提高患者的依从性。随着医疗保健提供者和患者寻求更有效、更方便的治疗选择，人们对将药物的治疗益处与医疗设备的精确性和可靠性结合起来的组合产品越来越感兴趣。此外，药物配方技术和设备设计的进步使得能够开发出适用于从慢性疾病到急性疾病等多种医疗状况的新型组合产品。此外，管理组合产品的监管倡议和指南，例如 FDA 的组合产品政策和欧盟的医疗器材法规 (MDR)，为製造商提供了一个框架，以应对复杂的监管环境并将创新产品推向市场。

此外，製药公司、医疗器材製造商和研究机构之间的策略合作推动创新和药械组合产品市场扩张，促进跨治疗领域新药械组合产品的开发。增加医疗保健支出和对组合产品的报销支持刺激了研发投资，进一步推动药物器材组合产品市场的成长。然而，与组合产品开发和报销挑战相关的监管障碍和复杂性可能会在未来几年挑战药物器械组合产品市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球药物器材组合产品市场的每个细分市场进行包容性评估。药物器械组合产品产业的成长和趋势为本研究提供了整体方法。

市场区隔

药品器材组合产品市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

  • 药物洗脱支架（冠状动脉药物洗脱支架、週边药物洗脱支架）
  • 输液帮浦（植入式输液帮浦、胰岛素输液帮浦、病人自控式止痛帮浦、行动输液帮浦、容量输液帮浦、一次性输液帮浦）
  • 光动力疗法
  • 伤口护理组合产品
  • 预灌封注射器（单室预灌封注射器、双室预灌封注射器、客製预灌封注射器）
  • 药物洗脱球囊（冠状动脉药物洗脱球囊、週边药物洗脱球囊）
  • 雾化器
  • 吸入器（药物粉末吸入器 (DPI)、定量吸入器 (MDI)、软雾吸入器 (SMI)）
  • 经皮给药系统（主动透皮系统、被动式透皮系统）
  • 骨科组合产品（骨移植植入物、抗生素骨水泥）
  • 抗菌导管（泌尿导管、心血管导管、其他导管、其他产品）

按申请

  • 心血管疾病
  • 糖尿病
  • 呼吸系统的问题
  • 癌症治疗
  • 抗菌应用
  • 其他

按最终用途

  • 医院和诊所
  • 门诊手术中心
  • 家庭护理设置
  • 其他

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的药物器械组合产品市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。药物器材组合产品市场的主要参与者包括雅培实验室、艾伯维公司、爱尔康公司、博士健康公司、百特国际公司、拜耳公司、Becton、迪金森公司、波士顿科学公司、葛兰素史克公司、强生公司Johnson、Kaleo Inc.、Medtronic Plc、Novartis AG、Sinomed、Smith & Nephew Plc、Teleflex Incorporated、Teva Pharmaceutical Industries Ltd. 本部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来能力、合作伙伴关係、财务概览、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：药物器械组合产品 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球药物器材组合产品市场分析：依产品分类

  • 概述（按产品）
  • 按产品分类的历史和预测资料分析
  • 药物洗脱支架（冠状动脉药物洗脱支架、週边药物洗脱支架）
  • 输液帮浦（植入式输液帮浦、胰岛素输液帮浦、病人自控式止痛帮浦、行动输液帮浦、容量输液帮浦、一次性输液帮浦）
  • 光动力疗法
  • 伤口护理组合产品
  • 预灌封注射器（单室预灌封注射器、双室预灌封注射器、客製预灌封注射器）
  • 药物洗脱球囊（冠状动脉药物洗脱球囊、週边药物洗脱球囊）
  • 雾化器
  • 吸入器（药物粉末吸入器 (DPI)、定量吸入器 (MDI)、软雾吸入器 (SMI)）
  • 经皮给药系统（主动透皮系统、被动式透皮系统）
  • 骨科组合产品（骨移植植入物、抗生素骨水泥）
  • 抗菌导管（泌尿导管、心血管导管、其他导管、其他产品）

第 6 章：全球药物器材组合产品市场分析：依应用分类

  • 概述：按应用
  • 历史与预测资料分析：按应用分类
  • 心血管疾病
  • 糖尿病
  • 呼吸系统的问题
  • 癌症治疗
  • 抗菌应用
  • 其他

第 7 章：全球药物器材组合产品市场分析：依最终用途分类

  • 按最终用途分类的概述
  • 按最终用途分类的历史和预测资料分析
  • 医院和诊所
  • 门诊手术中心
  • 家庭护理设置
  • 其他

第 8 章：全球药物器材组合产品市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章：药物器材组合产品公司的竞争格局

  • 药物器材组合产品市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Abbott Laboratories
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • AbbVie Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Alcon Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bausch Health Companies Inc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Baxter International Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bayer AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Becton, Dickinson And Company
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Teva Pharmaceutical Industries Ltd
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Boston Scientific Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GlaxoSmithKline Plc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Johnson & Johnson
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Kaleo Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Medtronic Plc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Novartis AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Sinomed
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Smith & Nephew Plc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Teleflex Incorporated
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112114874

The global demand for Drug Device Combination Products Market is presumed to reach the market size of nearly USD 296.74 Billion by 2032 from USD 144.66 Billion in 2023 with a CAGR of 8.31% under the study period 2024-2032.

Drug device combination products are medical products that combine a drug or biologic substance with a medical device to deliver therapeutic benefits or perform specific treatment functions. These products are designed to provide targeted drug delivery, enhance drug efficacy, improve patient compliance, or enable novel treatment modalities that may not be achievable with conventional drug formulations or medical devices alone. These products encompass various healthcare interventions, including drug-eluting stents, insulin pumps, contraceptive implants, and inhalation devices. These innovative products offer potential advantages in precision medicine, personalized therapy, and patient convenience, driving advancements in medical treatment and improving patient outcomes across various therapeutic areas.

MARKET DYNAMICS

The rising demand for tailored medicine and targeted therapies drives the development of innovative drug-device combination products that offer precise drug delivery mechanisms and improved patient compliance. As healthcare providers and patients seek more effective and convenient treatment options, there's a rising interest in combination products that combine pharmaceuticals' therapeutic benefits with medical devices' precision and reliability. Additionally, drug formulation technologies and device design advancements enable the development of novel combination products for numerous medical conditions, ranging from chronic diseases to acute conditions. Moreover, regulatory initiatives and guidelines governing combination products, such as the FDA's Combination Product Policy and the EU's Medical Device Regulation (MDR), provide a framework for manufacturers to navigate the complex regulatory landscape and bring innovative products to market.

Furthermore, strategic collaborations between pharmaceutical companies, medical device manufacturers, and research institutions drive innovation and drug-device combination products market expansion, fostering the development of new drug-device combination products across therapeutic areas. Increasing healthcare expenditure and reimbursement support for combination products incentivize investment in research and development, further driving drug-device combination products market growth. However, regulatory hurdles and complexities associated with combination product development and reimbursement challenges may challenge the drug device combination products market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Drug Device Combination Products. The growth and trends of Drug Device Combination Products industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Drug Device Combination Products market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Drug-Eluting Stents (Coronary Drug-Elating Stents, Peripheral Drug-Eluting Stents)
  • Infusion Pumps (Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps, Disposable Infusion Pumps)
  • Photodynamic Therapy
  • Wound Care Combination Product
  • Prefilled Syringes (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes)
  • Drug-Eluting Balloons (Coronary Drug-Eluting Balloons, Peripheral Drug-Eluting Balloons)
  • Nebulizers
  • Inhalers (Drug Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs))
  • Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems)
  • Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement)
  • Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products)

By Application

  • Cardiovascular Disorders
  • Diabetes
  • Respiratory Problems
  • Cancer Treatment
  • Antimicrobial Application
  • Other

By End-use

  • Hospitals And Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Drug Device Combination Products market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drug Device Combination Products market include Abbott Laboratories, AbbVie Inc., Alcon Inc., Bausch Health Companies Inc, Baxter International Inc., Bayer AG, Becton, Dickinson And Company, Boston Scientific Corporation, GlaxoSmithKline Plc, Johnson & Johnson, Kaleo Inc., Medtronic Plc, Novartis AG, Sinomed, Smith & Nephew Plc, Teleflex Incorporated, Teva Pharmaceutical Industries Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. DRUG DEVICE COMBINATION PRODUCTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Drug-Eluting Stents (Coronary Drug-Elating Stents, Peripheral Drug-Eluting Stents) Historic and Forecast Sales By Regions
  • 5.4. Infusion Pumps (Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps, Disposable Infusion Pumps) Historic and Forecast Sales By Regions
  • 5.5. Photodynamic Therapy Historic and Forecast Sales By Regions
  • 5.6. Wound Care Combination Product Historic and Forecast Sales By Regions
  • 5.7. Prefilled Syringes (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes) Historic and Forecast Sales By Regions
  • 5.8. Drug-Eluting Balloons (Coronary Drug-Eluting Balloons, Peripheral Drug-Eluting Balloons) Historic and Forecast Sales By Regions
  • 5.9. Nebulizers Historic and Forecast Sales By Regions
  • 5.10. Inhalers (Drug Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs)) Historic and Forecast Sales By Regions
  • 5.11. Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems) Historic and Forecast Sales By Regions
  • 5.12. Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement) Historic and Forecast Sales By Regions
  • 5.13. Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products) Historic and Forecast Sales By Regions

6. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Cardiovascular Disorders Historic and Forecast Sales By Regions
  • 6.4. Diabetes Historic and Forecast Sales By Regions
  • 6.5. Respiratory Problems Historic and Forecast Sales By Regions
  • 6.6. Cancer Treatment Historic and Forecast Sales By Regions
  • 6.7. Antimicrobial Application Historic and Forecast Sales By Regions
  • 6.8. Other Historic and Forecast Sales By Regions

7. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-use
  • 7.2. Historical and Forecast Data Analysis By End-use
  • 7.3. Hospitals And Clinics Historic and Forecast Sales By Regions
  • 7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 7.5. Home Care Settings Historic and Forecast Sales By Regions
  • 7.6. Other Historic and Forecast Sales By Regions

8. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE DRUG DEVICE COMBINATION PRODUCTS COMPANIES

  • 9.1. Drug Device Combination Products Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF DRUG DEVICE COMBINATION PRODUCTS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abbott Laboratories
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. AbbVie Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Alcon Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Bausch Health Companies Inc
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Baxter International Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Bayer AG
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Becton, Dickinson And Company
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Teva Pharmaceutical Industries Ltd
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Boston Scientific Corporation
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. GlaxoSmithKline Plc
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Johnson & Johnson
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Kaleo Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Medtronic Plc
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Novartis AG
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. Sinomed
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments
  • 10.18. Smith & Nephew Plc
    • 10.18.1 Company Overview
    • 10.18.2 Company Revenue
    • 10.18.3 Products
    • 10.18.4 Recent Developments
  • 10.19. Teleflex Incorporated
    • 10.19.1 Company Overview
    • 10.19.2 Company Revenue
    • 10.19.3 Products
    • 10.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Drug-Eluting Stents (Coronary Drug-Elating Stents, Peripheral Drug-Eluting Stents) Market Sales By Geography (USD MN)
  • Infusion Pumps (Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps, Disposable Infusion Pumps) Market Sales By Geography (USD MN)
  • Photodynamic Therapy Market Sales By Geography (USD MN)
  • Wound Care Combination Product Market Sales By Geography (USD MN)
  • Prefilled Syringes (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes) Market Sales By Geography (USD MN)
  • Drug-Eluting Balloons (Coronary Drug-Eluting Balloons, Peripheral Drug-Eluting Balloons) Market Sales By Geography (USD MN)
  • Nebulizers Market Sales By Geography (USD MN)
  • Inhalers (Drug Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs)) Market Sales By Geography (USD MN)
  • Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems) Market Sales By Geography (USD MN)
  • Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement) Market Sales By Geography (USD MN)
  • Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Cardiovascular Disorders Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Respiratory Problems Market Sales By Geography (USD MN)
  • Cancer Treatment Market Sales By Geography (USD MN)
  • Antimicrobial Application Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals And Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Home Care Settings Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Drug Device Combination Products Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Drug Device Combination Products Report
  • Market Research Process
  • Market Research Methodology
  • Global Drug Device Combination Products Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Drug-Eluting Stents (Coronary Drug-Elating Stents, Peripheral Drug-Eluting Stents) Market Sales By Geography (USD MN)
  • Infusion Pumps (Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps, Disposable Infusion Pumps) Market Sales By Geography (USD MN)
  • Photodynamic Therapy Market Sales By Geography (USD MN)
  • Wound Care Combination Product Market Sales By Geography (USD MN)
  • Prefilled Syringes (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes) Market Sales By Geography (USD MN)
  • Drug-Eluting Balloons (Coronary Drug-Eluting Balloons, Peripheral Drug-Eluting Balloons) Market Sales By Geography (USD MN)
  • Nebulizers Market Sales By Geography (USD MN)
  • Inhalers (Drug Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs)) Market Sales By Geography (USD MN)
  • Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems) Market Sales By Geography (USD MN)
  • Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement) Market Sales By Geography (USD MN)
  • Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Cardiovascular Disorders Market Sales By Geography (USD MN)
  • Diabetes Market Sales By Geography (USD MN)
  • Respiratory Problems Market Sales By Geography (USD MN)
  • Cancer Treatment Market Sales By Geography (USD MN)
  • Antimicrobial Application Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals And Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Home Care Settings Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.